Journal articles
Gelsolin and plasma gelsolin biochemistry and actions
Bucki R, Georges PC, Espinassous Q, Funaki M, J. Pastore JJ, Chaby R, Janmey PA: Inactivation of Endotoxin by Human Plasma Gelsolin. Biochem 2005;44: 9590-9597.
Lee, WM, Galbraith, RM: The extra cellular actin-scavenger system and actin toxicity. N Engl J Med 1992; 326: 1335-1341.
Osborn, T, Dahlgren C, Hartwig JH, Stossel TP: Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 2007;292: C1323-1330.
Goetzl EJ, Lee H, Azuma T, Stossel TP, Turck CW, Karliner JS: Gelsolin binding and cellular presentation of lysophosphatidic acid. J Bio Chem 2000;275: 14573-14578. .
Vasconellos, C, Allen, PG, Wohl, ME, Drazen, JM, Janmey, PA, Stossel, TP: Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 263: 969-971.
Wen, D, Corina, K, Chow, EP, Miller, S, Janmey, PA, Pepinsky, RB: The plasma and cytoplasmic forms of human gelsolin differ in disulfide structure. Biochem 1996; 35: 9700-9709.
Plasma gelsolin in patients
Dahl, B, Schiødt, FV, Ott, P, Gvozdenovic, R, Yin, HL, Lee, WM: Plasma gelsolin is reduced in trauma patients. Shock 1999; 12: 10-104.
DiNubile, MJ, Stossel, TP, Ljunghusen, OC, Ferrara, JF, Antin, JH: Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation. Blood 2002; 100: 4367-4371.
Lee, P-S, Drager, L, Stossel, TP, Moore, FD Jr, Rogers, SO: Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients. Ann Surg 2006; 243: 399–403.
Lind, SE, Smith, DB, Janmey, PA, Stossel, TP. Depression of gelsolin levels and detection of actin-gelsolin complexes in plasma of patients with acute lung injury. Am Rev Resp Dis 1988; 138: 429-434.
Mounzer, KC, Moncure, M, Smith, YR, DiNubile, MJ: Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am R Respir Crit Care Med 1999; 160: 1673-1681
Smith DB, Janmey PA, Sherwood JA, Howard RJ, Lind SE: Decreased plasma gelsolin levels in patients with Plasmodium falciparum. Blood 1988; 72: 214-218.
Suhler, E, Lin, W, Yin, HL, Lee, WM: Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med 1997; 25: 594-598.
Gelsolin in animal studies
Becker, PM, Kazi, AA, Wadgaonkar, R, Pearse, DB, Kwiatkowski, DJ, Garcia, JGN: Pulmonary vascular permeability and ischemic injury in gelsolin-deficient mice. Am J Resp Cell Mol Biol 2003; 28: 478-484.
Christofidou-Solomidou, M, Scherpereel, A, Solomides, CC, Muzykantov, VR, Machthay, M, Albelda, SM, DiNubile, MJ: Changes in plasma gelsolin concentration during acute oxidant lung injury in mice. Lung 2002; 180: 91-104.
Christofidou-Solomidou, M, Scherperrel, A, Solomides, CC, Christie, JD, Stossel, TP, DiNubile, MJ: Recombinant plasma gelsolin diminishes the acute inflammatory response to hyperoxia in mice. J Invest Med 2002; 50: 54-60.
Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP: Plasma gelsolin is a marker and therapeutic agent in animal sepsis.Crit Care Med 2007; 35: 849–855.
Rothenbach, PA, Schwartz, JJ, Dahl, B, O’Keefe, E, Yamamoto, Y, Lee, WM, Horton, JW, Yin, HL, Turnage, RH: Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Applied Physiol 2003; 96: 25-31.
Smith DB, Jamney PA, Lind SE. Circulating Actin-Gelsolin Complexes Following Oleic Acid-Induced Lung Injury. Am J Pathol 1988; 130: 261-267.
